Research theme for competitive and other funds (17):
2023 - 2025 Development of covalent protein drug with unnatural amino acids
2020 - 2023 抗原の動態制御に基づく有効かつ安全な新規経鼻ワクチン創製基盤の構築
2020 - 2022 Hitchhiking vaccine using natural antibody as an antigen delivery carrier
2018 - 2020 Towards the development of intrapulmonary vaccine for cancer
2017 - 2020 Development of peptides that target immune cells and their application for therapy of immune-related diseases
2015 - 2017 Virus Like Nano-Particle as the delivery tool of vaccine adjuvant
2015 - 2017 The potential of self-polymerizing Spy0128 as vaccine adjuvant
2014 - 2016 Challenge for the development of vaccine without the production of IgE
2013 - 2016 Development of a new drug candidate to stimulate bone formation by oligomerization of RANKL-binding peptides
2012 - 2016 Development of novel nanomedicine for metabolic syndrome
2013 - 2015 ナノマテリアルの細胞内ADMEに関する数理モデルの構築
2012 - 2014 Development of in vitro embryotoxic test for nanomaterials
2011 - 2013 ナノDDS医薬の安全性予測/評価システムの構築
2009 - 2010 Reproductive toxicity of nanomaterials for the development of nanomedicine with safety and efficacy
2006 - 2007 食品由来ポリフェノールによる炎症性腸疾患に対する新たな創薬戦略の開発
組織特異的移行能を有するデバイスの開発
Development of the device for organ targeting.
Show all
Papers (255):
Hibiki Sakai, Hiroyasu Kamuro, Nagisa Tokunoh, Takeshi Izawa, Shigeyuki Tamiya, Ayaha Yamamoto, Shota Tanaka, Daisuke Okuzaki, Chikako Ono, Yoshiharu Matsuura, et al. JAK inhibition during the early phase of SARS-CoV-2 infection worsens kidney injury by suppressing endogenous antiviral activity in mice. American journal of physiology. Renal physiology. 2024
Takuto Nogimori, Yuta Nagatsuka, Shogo Kobayashi, Hirotomo Murakami, Yuji Masuta, Koichiro Suzuki, Yoshito Tomimaru, Takehiro Noda, Hirofumi Akita, Shokichi Takahama, et al. Humoral and cellular immune responses to COVID-19 mRNA vaccines in immunosuppressed liver transplant recipients. Communications medicine. 2024. 4. 1. 30-30
Eigo Kawahara, Shinya Yamamoto, Takehiko Shibata, Toshiro Hirai, Yasuo Yoshioka. CpG ODN enhances the efficacy of F protein vaccine against respiratory syncytial virus infection in the upper respiratory tract via CD4+ T cells. Biochemical and biophysical research communications. 2023. 686. 149143-149143
加藤吏恵, 宗像理紗, 青枝大貴, 小山正平, 小山正平, 小俣大樹, 鈴木悠乃, 岡田欣晃, 吉岡靖雄, 吉岡靖雄, et al. Development of effective cancer immunotherapy for Cold tumor. 日本薬学会年会要旨集(Web). 2023. 143rd
2009 - International Cytokine Society, ICS Young Investigation Award
2003 - 日本薬学会近畿支部 支部奨励賞
2003 - 日本薬剤学会第18年会 最優秀論文発表賞
2002 - ファーマ・バイオフォーラム 2002 最優秀発表賞
Show all
Association Membership(s) (7):
THE JAPANESE SOCIETY FOR VACCINOLOGY
, JAPANESE COSMETIC SCIENCE SOCIETY
, 日本免疫毒性学会
, THE JAPANESE SOCIETY OF TOXICOLOGY
, THE PHARMACEUTICAL SOCIETY OF JAPAN
, THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
, THE JAPANESE SOCIETY FOR IMMUNOLOGY